These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20158615)

  • 1. Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat.
    Yüce B; Kemmer M; Qian G; Müller M; Sibaev A; Li Y; Kreis ME; Storr M
    Neurogastroenterol Motil; 2010 Jun; 22(6):672-e205. PubMed ID: 20158615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum.
    Donnerer J; Liebmann I
    Pharmacology; 2018; 101(5-6):330-336. PubMed ID: 29627825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon.
    Sibaev A; Yüce B; Kemmer M; Van Nassauw L; Broedl U; Allescher HD; Göke B; Timmermans JP; Storr M
    Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G119-28. PubMed ID: 19033531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A.
    Pozzi O; Misiano P; Clark GD; Visentin L
    Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
    Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
    Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
    Rodvelt KR; Bumgarner DM; Putnam WC; Miller DK
    Life Sci; 2007 Jan; 80(4):337-44. PubMed ID: 17067637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
    Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.
    Gifford AN; Ashby CR
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways.
    Yoshihara S; Morimoto H; Yamada Y; Abe T; Arisaka O
    Am J Respir Crit Care Med; 2004 Nov; 170(9):941-6. PubMed ID: 15306537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide.
    Melis MR; Succu S; Mascia MS; Sanna F; Melis T; Castelli MP; Argiolas A
    Neuropharmacology; 2006 Feb; 50(2):219-28. PubMed ID: 16288932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
    Coutts AA; Pertwee RG
    Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse.
    Mancinelli R; Fabrizi A; Del Monaco S; Azzena GB; Vargiu R; Colombo GC; Gessa GL
    Life Sci; 2001 May; 69(1):101-11. PubMed ID: 11411800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors.
    Izzo AA; Mascolo N; Borrelli F; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):65-70. PubMed ID: 9933153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.
    Guagnini F; Cogliati P; Mukenge S; Ferla G; Croci T
    Br J Pharmacol; 2006 Aug; 148(8):1165-73. PubMed ID: 16783406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.